These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18362284)

  • 1. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
    Zaccai J; Brayne C; McKeith I; Matthews F; Ince PG;
    Neurology; 2008 Mar; 70(13):1042-8. PubMed ID: 18362284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85.
    Raunio A; Kaivola K; Tuimala J; Kero M; Oinas M; Polvikoski T; Paetau A; Tienari PJ; Myllykangas L
    Acta Neuropathol; 2019 Nov; 138(5):771-782. PubMed ID: 31494694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.
    Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA
    Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between cortical and subcortical tau pathology.
    Attems J; Thomas A; Jellinger K
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):582-90. PubMed ID: 22115520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation and development of Lewy pathology: a critical update.
    Jellinger KA
    J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.
    Uchikado H; Lin WL; DeLucia MW; Dickson DW
    J Neuropathol Exp Neurol; 2006 Jul; 65(7):685-97. PubMed ID: 16825955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical evaluation of the Braak staging scheme for Parkinson's disease.
    Burke RE; Dauer WT; Vonsattel JP
    Ann Neurol; 2008 Nov; 64(5):485-91. PubMed ID: 19067353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.
    Toledo JB; Gopal P; Raible K; Irwin DJ; Brettschneider J; Sedor S; Waits K; Boluda S; Grossman M; Van Deerlin VM; Lee EB; Arnold SE; Duda JE; Hurtig H; Lee VM; Adler CH; Beach TG; Trojanowski JQ
    Acta Neuropathol; 2016 Mar; 131(3):393-409. PubMed ID: 26721587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly.
    Zaccai J; Brayne C; Matthews FE; Ince PG;
    Alzheimers Res Ther; 2015; 7(1):19. PubMed ID: 25870655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?
    Frigerio R; Fujishiro H; Ahn TB; Josephs KA; Maraganore DM; DelleDonne A; Parisi JE; Klos KJ; Boeve BF; Dickson DW; Ahlskog JE
    Neurobiol Aging; 2011 May; 32(5):857-63. PubMed ID: 19560232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
    Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
    J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
    Kingsbury AE; Bandopadhyay R; Silveira-Moriyama L; Ayling H; Kallis C; Sterlacci W; Maeir H; Poewe W; Lees AJ
    Mov Disord; 2010 Nov; 25(15):2508-15. PubMed ID: 20818670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.
    Schneider JA; Arvanitakis Z; Yu L; Boyle PA; Leurgans SE; Bennett DA
    Brain; 2012 Oct; 135(Pt 10):3005-14. PubMed ID: 23065790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence in favor of Braak staging of Parkinson's disease.
    Dickson DW; Uchikado H; Fujishiro H; Tsuboi Y
    Mov Disord; 2010; 25 Suppl 1():S78-82. PubMed ID: 20187227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.
    Fujishiro H; Tsuboi Y; Lin WL; Uchikado H; Dickson DW
    Acta Neuropathol; 2008 Jul; 116(1):17-24. PubMed ID: 18446351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.